Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cornelius Knabbe

Showing results (61-70 of 178) with videos related to

Pageof 18
Sort By:
Platelets|November 20, 2013
Non-transient "self-sustaining" heparin-induced thrombocytopenia: 4-year persistence of a platelet-activating PF4/heparin-antibody status without heparin exposureIngvild Birschmann, Jan Gummert, Uwe Schirmer, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|March 30, 2016
Implementation of NAT Screening for West Nile Virus and Experience with Seasonal Testing in GermanyJens Dreier, Tanja Vollmer, Dennis Hinse, et al.
Anticancer Research|May 23, 2002
The influence of tamoxifen on the secretion of transforming growth factor-beta2 (TGF-beta2) in glioblastomas: in vitro and in vivo findingsMaximilian J A Puchner, Johannes A Köppen, Svenja Zapf, et al.
BMC Genetics|December 7, 2014
First description of the complete human xylosyltransferase-I promoter regionIsabel Faust, Kai Oliver Böker, Christoph Lichtenberg, et al.
Health Science Reports|August 12, 2022
Retrospective study shows that early administration of convalescent plasma in hospitalized COVID-19 patients may have a positive effect on disease progressionIngvild Birschmann, Katharina von Bargen, Michelle Teune, et al.
Breast Cancer Research and Treatment|November 29, 2007
TGFbeta2 and TbetaRII are valid molecular biomarkers for the antiproliferative effects of tamoxifen and tamoxifen metabolites in breast cancer cellsMiriam B Buck, Janet K Coller, Thomas E Mürdter, et al.
European Heart Journal|January 15, 2013
Vitamin D status and the risk of major adverse cardiac and cerebrovascular events in cardiac surgeryArmin Zittermann, Joachim Kuhn, Jens Dreier, et al.
Blood Transfusion = Trasfusione Del Sangue|June 3, 2014
Bacterial screening of platelet concentrates on day 2 and 3 with flow cytometry: the optimal sampling time point?Tanja Vollmer, Volkmar Schottstedt, Juergen Bux, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 27, 2022
Humoral and cellular immune response levels at a 1-year follow-up after mild COVID-19Tobias Flieder, Bastian Fischer, Katharina von Bargen, et al.
Cells|April 25, 2025
Investigation on ABCC6-Deficient Human Hepatocytes Generated by CRISPR-Cas9 Genome EditingRicarda Plümers, Svenja Jelinek, Christopher Lindenkamp, et al.
Pageof 18

Showing results (61-70 of 178) with videos related to

Sort By:
Pageof 18
Platelets|November 20, 2013
Non-transient "self-sustaining" heparin-induced thrombocytopenia: 4-year persistence of a platelet-activating PF4/heparin-antibody status without heparin exposureIngvild Birschmann, Jan Gummert, Uwe Schirmer, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|March 30, 2016
Implementation of NAT Screening for West Nile Virus and Experience with Seasonal Testing in GermanyJens Dreier, Tanja Vollmer, Dennis Hinse, et al.
Anticancer Research|May 23, 2002
The influence of tamoxifen on the secretion of transforming growth factor-beta2 (TGF-beta2) in glioblastomas: in vitro and in vivo findingsMaximilian J A Puchner, Johannes A Köppen, Svenja Zapf, et al.
BMC Genetics|December 7, 2014
First description of the complete human xylosyltransferase-I promoter regionIsabel Faust, Kai Oliver Böker, Christoph Lichtenberg, et al.
Health Science Reports|August 12, 2022
Retrospective study shows that early administration of convalescent plasma in hospitalized COVID-19 patients may have a positive effect on disease progressionIngvild Birschmann, Katharina von Bargen, Michelle Teune, et al.
Breast Cancer Research and Treatment|November 29, 2007
TGFbeta2 and TbetaRII are valid molecular biomarkers for the antiproliferative effects of tamoxifen and tamoxifen metabolites in breast cancer cellsMiriam B Buck, Janet K Coller, Thomas E Mürdter, et al.
European Heart Journal|January 15, 2013
Vitamin D status and the risk of major adverse cardiac and cerebrovascular events in cardiac surgeryArmin Zittermann, Joachim Kuhn, Jens Dreier, et al.
Blood Transfusion = Trasfusione Del Sangue|June 3, 2014
Bacterial screening of platelet concentrates on day 2 and 3 with flow cytometry: the optimal sampling time point?Tanja Vollmer, Volkmar Schottstedt, Juergen Bux, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 27, 2022
Humoral and cellular immune response levels at a 1-year follow-up after mild COVID-19Tobias Flieder, Bastian Fischer, Katharina von Bargen, et al.
Cells|April 25, 2025
Investigation on ABCC6-Deficient Human Hepatocytes Generated by CRISPR-Cas9 Genome EditingRicarda Plümers, Svenja Jelinek, Christopher Lindenkamp, et al.
Pageof 18